Chris Mason PhD
Chris co-founded five biotechnology start-up companies (Genome Liberty, Biotia, Onegevity Health, P-Omics, and Shanghai GeneTech) and serves as an advisor to many others.
Dr. Christopher Mason’s background and appointments:
- BS. in Genetics, University of Wisconsin-Madison (2001)
- BS. in Biochemistry, University of Wisconsin-Madison (2001)
- PhD. in Genetics, Yale University (2006)
- Post-doc, Clinical Genetics, Yale Medical School (2009)
- Fellowship of Genomics, Ethics, and Law, Yale Law School (2009).
- Assistant Professor, Weill Cornell Medicine (2009)
- Associate Professor, Weill Cornell Medicine (2015)
- Director, the WorldQuant Initiative for Quantitative Prediction (2017),
- Appointments at the Tri-Institutional Program on Computational Biology and Medicine between Cornell, Memorial Sloan-Kettering Cancer Center and Rockefeller University, the Sandra and Edward Meyer Cancer Center, and the Feil Family Brain and Mind Research Institute.
The Mason laboratory develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and human physiology. We create and deploy novel techniques in next-generation sequencing and algorithms for: tumor evolution, genome evolution, DNA and RNA modifications, and genome/epigenome engineering. We also work closely with NIST/FDA to build international standards for these methods (SEQC2, IMMSA, and Epigenomics QC groups), to ensure clinical-quality genome measurements and editing. We also work with NASA to build integrated molecular portraits of genomes, epigenomes, transcriptomes, and metagenomes for astronauts, which help establish the molecular foundations and genetic defenses for enabling long-term human spaceflight.
He has won the NIH’s Transformative R01 Award, the NASA Group Achievement Award, the Pershing Square Sohn Cancer Research Alliance Young Investigator award, the Hirschl-Weill-Caulier Career Scientist Award, the Vallee Scholar Award, the CDC Honor Award for Standardization of Clinical Testing, and the WorldQuant Foundation Scholar Award. He was named as one of the “Brilliant Ten” Scientists by Popular Science, featured as a TEDMED speaker, and called “The Genius of Genetics” by 92Y. He has >175 peer-reviewed papers that have been featured on the covers of Nature, Science, Cell, Nature Biotechnology, Nature Microbiology, and Neuron, as well as cited by the U.S. District Court and U.S. Supreme Court. Coverage of his work has also appeared on the covers of the Wall Street Journal, New York Times, TIME, The LA Times, and across many media (ABC, NBC, CBC, CBS, Fox, CNN, PBS, NASA, NatGeo). He has co-founded five biotechnology start-up companies (Genome Liberty, Biotia, Onegevity Health, P-Omics, and Shanghai GeneTech) and serves as an advisor to many others. He lives with his daughter and wife in Brooklyn, NY.